Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 102Thoracic 46Head & Neck 33Breast 31CNS 22Sarcoma 17Genitourinary 11Gynecologic 10Dermatologic 9Tumor-Agnostic 2Other solid neoplasm 2Other 1Endocrine 1Classical hematology 1

Conditions

Peritoneal Neoplasms 1Mesothelioma 1DMMR Colorectal Cancer 1Colonic Neoplasms 1Abdominal Neoplasms 1

Interventions

Cisplatin 42Pemetrexed 31Carboplatin 28Nivolumab 21pembrolizumab 19Gemcitabine 19atezolizumab 13Etoposide 13Injections 12Ipilimumab 11Cyclophosphamide 11Radiotherapy 10Oxaliplatin 10Filgrastim 10Docetaxel 10Bevacizumab 10tislelizumab 9Vincristine 9Specimen Handling 9durvalumab 8Paclitaxel 8Capecitabine 8tremelimumab 7toripalimab 7lenvatinib 7Everolimus 7spartalizumab 6olaparib 6niraparib 6Vinorelbine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Surgical Procedures, Operative × Other solid neoplasm × Clear all
NCT06262581 2024-02-16

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer

NCT00004547 2015-11-18

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
188 enrolled 11 charts
GastrointestinalGynecologicOther solid neoplasmThoracic

Abdominal Neoplasms, Colonic Neoplasms, Mesothelioma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡